Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 1
2007 5
2008 3
2009 2
2010 3
2011 5
2012 9
2013 7
2014 10
2015 9
2016 11
2017 7
2018 7
2019 3
2020 7
2021 6
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease.
Tupini C, Chilin A, Rossi A, De Fino I, Bragonzi A, D'Aversa E, Cosenza LC, Vaccarin C, Sacchetti G, Borgatti M, Tamanini A, Dechecchi MC, Sanvito F, Gambari R, Cabrini G, Lampronti I. Tupini C, et al. Among authors: bragonzi a. Int J Mol Sci. 2022 Nov 21;23(22):14483. doi: 10.3390/ijms232214483. Int J Mol Sci. 2022. PMID: 36430961 Free PMC article.
Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosis.
Brindisi M, Barone S, Rossi A, Cassese E, Del Gaudio N, Feliz Morel ÁJ, Filocamo G, Alberico A, De Fino I, Gugliandolo D, Babaei M, Bove G, Croce M, Montesano C, Altucci L, Bragonzi A, Summa V. Brindisi M, et al. Among authors: bragonzi a. Eur J Pharmacol. 2022 Dec 5;936:175349. doi: 10.1016/j.ejphar.2022.175349. Epub 2022 Oct 26. Eur J Pharmacol. 2022. PMID: 36309047
Biocompatible antimicrobial colistin loaded calcium phosphate nanoparticles for the counteraction of biofilm formation in cystic fibrosis related infections.
Iafisco M, Carella F, Degli Esposti L, Adamiano A, Catalucci D, Modica J, Bragonzi A, Vitali A, Torelli R, Sanguinetti M, Bugli F. Iafisco M, et al. Among authors: bragonzi a. J Inorg Biochem. 2022 May;230:111751. doi: 10.1016/j.jinorgbio.2022.111751. Epub 2022 Feb 5. J Inorg Biochem. 2022. PMID: 35151101
R othia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease.
Rigauts C, Aizawa J, Taylor SL, Rogers GB, Govaerts M, Cos P, Ostyn L, Sims S, Vandeplassche E, Sze M, Dondelinger Y, Vereecke L, Van Acker H, Simpson JL, Burr L, Willems A, Tunney MM, Cigana C, Bragonzi A, Coenye T, Crabbé A. Rigauts C, et al. Among authors: bragonzi a. Eur Respir J. 2022 May 5;59(5):2101293. doi: 10.1183/13993003.01293-2021. Print 2022 May. Eur Respir J. 2022. PMID: 34588194 Free PMC article.
Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis.
Totani L, Amore C, Piccoli A, Dell'Elba G, Di Santo A, Plebani R, Pecce R, Martelli N, Rossi A, Ranucci S, De Fino I, Moretti P, Bragonzi A, Romano M, Evangelista V. Totani L, et al. Among authors: bragonzi a. Front Pharmacol. 2021 Sep 8;12:702677. doi: 10.3389/fphar.2021.702677. eCollection 2021. Front Pharmacol. 2021. PMID: 34566635 Free PMC article.
94 results